Table 26.
Trial no (month) | Inoculum characteristics | Feed analysis lasalocid A Na + nicarbazin (mg/kg feed)1) | ||
---|---|---|---|---|
Country and date of isolation | Intended dose (number of oocysts and strain per bird) | |||
AST‐1 (Jan) | Netherlands Feb 2016 | 2,621 | E. acervulina | 27.9 + 29.8 39.1 + 38.6 47.8 + 52.2 |
93,339 | E. maxima | |||
AST‐2 (Jul) | Germany May 2017 | 82,000 | E. acervulina | 31.4 + 28.6 43.2 + 38.9 53.1 + 48.1 |
62,000 | E. tenella | |||
14,000 | E. mitis | |||
8,000 | E. maxima | |||
AST‐3 (Aug) | France May 2017 | 52,000 | E. acervulina | 31.4 + 28.6 43.2 + 38.9 53.1 + 48.1 |
17,500 | E. tenella | |||
10,000 | E. maxima | |||
1,000 | E. mitis | |||
AST‐4 (Oct) | Belgium Aug 2017 | 101,000 | E. acervulina | 30.9 + 28.3 42.0 + 37.9 |
20,000 | E. tenella | |||
67,000 | E. maxima | |||
AST‐5 (Nov) | UK June 2017 | 294,000 | E. acervulina | 30.9 + 28.3 |
54,000 | E. tenella | 42.0 + 37.9 | ||
2,000 | E. mitis |
Three infected treated groups (IT30, IT40 and IT50) in AST‐1, AST‐2 and AST‐3 two infected treated groups (IT30 and IT40) in AST‐4 and AST‐5.